Stockscreener 앱 받기
2.78
0.71%
-0.02
전일 마감가:
$2.80
열려 있는:
$2.72
하루 거래량:
23,988
Relative Volume:
0.44
시가총액:
$89.19M
수익:
-
순이익/손실:
$-24.74M
주가수익비율:
-0.148
EPS:
-18.7859
순현금흐름:
$-15.75M
1주 성능:
-2.46%
1개월 성능:
-56.77%
6개월 성능:
-38.22%
1년 성능:
+44.04%
1일 변동 폭
$2.705
$2.80
1주일 범위
$2.60
$3.1528
52주 변동 폭
$1.87
$29.28
Dogwood Therapeutics Inc Stock (DWTX) Company Profile
명칭
Dogwood Therapeutics Inc
전화
(866) 620-8655
주소
44 MILTON AVENUE, ALPHARETTA
DWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DWTX
Dogwood Therapeutics Inc
|
2.78 | 89.83M | 0 | -24.74M | -15.75M | -18.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Dogwood Therapeutics Inc 주식(DWTX)의 최신 뉴스
Trend Report: Does ATUS stock have upside surprise potentialJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
Retail Trends: Is Dogwood Therapeutics Inc stock showing strong momentumMarket Activity Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
Support Test: Is Dogwood Therapeutics Inc stock showing strong momentumJuly 2025 Closing Moves & Advanced Technical Signal Analysis - baoquankhu1.vn
Geopolitics Watch: Will Dogwood Therapeutics Inc stock maintain momentum in 2025Bull Run & Free Daily Entry Point Trade Alerts - Bộ Nội Vụ
Dogwood Therapeutics Raises Capital via Registered Direct Financing - TipRanks
Dogwood Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
Bull Run: Can Dogwood Therapeutics Inc stock sustain revenue growthJuly 2025 Breakouts & High Accuracy Trade Alerts - Bộ Nội Vụ
Risk Off: Whats Dogwood Therapeutics Incs historical return2025 Historical Comparison & Weekly High Return Stock Forecasts - baoquankhu1.vn
Dogwood Therapeutics, Inc. Announces Financing of up to $26.8 Million to Progress Halneuron® Through Phase 2b Development - TradingView — Track All Markets
New funding backs a non-opioid drug for chemotherapy nerve pain - Stock Titan
Will Dogwood Therapeutics Inc. stock continue upward momentum2025 Year in Review & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Will Dogwood Therapeutics Inc. stock recover faster than market2025 Major Catalysts & Capital Efficiency Focused Ideas - ulpravda.ru
Will Dogwood Therapeutics Inc. stock split again soonJuly 2025 Macro Moves & Weekly Hot Stock Watchlists - Улправда
Why Dogwood Therapeutics Inc. stock is trending among retail tradersInsider Selling & Weekly Setup with High ROI Potential - ulpravda.ru
Can Dogwood Therapeutics Inc. stock hit record highs againJuly 2025 WrapUp & Fast Entry High Yield Tips - Улправда
What technical charts say about Dogwood Therapeutics Inc. stock2025 Performance Recap & Daily Entry Point Trade Alerts - Улправда
Momentum Shift: Will Dogwood Therapeutics Inc. stock recover faster than market2025 Major Catalysts & Capital Efficiency Focused Ideas - Улправда
How sustainable is Dogwood Therapeutics Inc. stock dividend payout2025 Earnings Surprises & Accurate Technical Buy Alerts - Улправда
Why Dogwood Therapeutics Inc. stock remains a top recommendationEx-Dividend Date Alerts & Rapid Wealth Building Tips - Улправда
Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Surge - MSN
Can Dogwood Therapeutics Inc. stock rebound after recent weaknessEarnings Season Recap & Add These Before Everyone Else Does - bollywoodhelpline.com
DWTX: Positive Interim Results for Halneuron Phase 2b Trial in CINP Raising Valuation to 15 - Research Tree
Aug Chart Watch: What hedge fund activity signals for Dogwood Therapeutics Inc stockProfit Target & Stock Portfolio Risk Management - moha.gov.vn
DWTX: Positive Interim Results for Halneuron® Phase 2b Trial in CINP; Raising Valuation to $15 - Zacks Small Cap Research
Trading Recap: Can Dogwood Therapeutics Inc stock hit record highs againJuly 2025 Final Week & Risk Managed Investment Entry Signals - moha.gov.vn
What date does Dogwood Therapeutics, Inc's (DWTX) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Aug Big Picture: Will Dogwood Therapeutics Inc stock continue upward momentumTrade Risk Assessment & Safe Entry Point Alerts - moha.gov.vn
What's Driving the Market Sentiment Around Dogwood Therapeutics Inc? - Benzinga
Halneuron Shows Pain Relief Separation In Interim Phase 2b Trial - Nasdaq
CKLIFE SCIENCES: Positive Results Obtained from Interim Analysis of Halneuron Phase 2b Study - AASTOCKS.com
DWTX Stock Heads For Worst Day In 9 Months As Chemotherapy Pain Drug Interim Study Data Fails To Boost Investor Confidence - Stocktwits
Dogwood Therapeutics stock plummets after Phase 2b interim results By Investing.com - Investing.com South Africa
Dogwood Therapeutics stock plummets after Phase 2b interim results - Investing.com
Dogwood Therapeutics reports positive interim phase 2b results in chemotherapy-induced neuropathic pain - marketscreener.com
Dogwood Therapeutics Says Interim Phase 2B Data Show Pain Improvement With Halneuron - marketscreener.com
Dogwood reports positive interim results for pain treatment By Investing.com - Investing.com South Africa
Dogwood Therapeutics Announces Positive Interim Phase 2b Clinical Trial Results in Chemotherapy Induced Neuropathic Pain - The Manila Times
Dogwood Therapeutics Announces Positive Interim Phase 2b - GlobeNewswire
Can Dogwood Therapeutics Inc. stock sustain institutional interestQuarterly Profit Report & Smart Swing Trading Alerts - ulpravda.ru
Why retail investors favor Dogwood Therapeutics Inc. stockJuly 2025 Big Picture & Safe Swing Trade Setups - Улправда
Published on: 2025-12-21 10:22:42 - moha.gov.vn
Is Dogwood Therapeutics Inc. stock a bargain at current levelsJuly 2025 Action & Weekly Setup with ROI Potential - Улправда
Why Dogwood Therapeutics Inc. stock is recommended by analystsJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - Улправда
What hedge fund activity signals for Dogwood Therapeutics Inc. stock2025 Sector Review & Smart Swing Trading Alerts - DonanımHaber
Stock Market Recap: Why Dogwood Therapeutics Inc. stock is recommended by analysts2025 Market Overview & Safe Capital Preservation Plans - Улправда
Aug Macro: Can Dogwood Therapeutics Inc. stock sustain institutional interest2025 Top Gainers & Safe Entry Trade Reports - Улправда
Dogwood Therapeutics Earnings Notes - Trefis
Can Dogwood Therapeutics Inc. stock outperform in 2025 bull market2025 Risk Factors & Low Drawdown Momentum Ideas - Newser
Why Dogwood Therapeutics Inc. stock is in analyst buy zonePortfolio Gains Report & Daily Technical Forecast Reports - Newser
Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045 - ACCESS Newswire
Dogwood Therapeutics (Nasdaq: DWTX) files synthetic Halneuron IP, eyes 2045 exclusivity - Stock Titan
Dogwood Therapeutics Inc (DWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):